The latest headlines across every section, pulled from official and open-access sources.
Resources for World Antimicrobial Resistance Awareness Week (WAAW) and European Antibiotic Awareness Day (EAAD) for healthcare professionals in England.
The investment will add J&J’s manufacturing, packaging and distribution capabilities to meet growing demand for its contact lenses.
The proposed Medicare coverage change could help Edwards Lifesciences gain market share from Medtronic and Boston Scientific, an analyst said.
Official statistics in development on adult social care activity including data on requests for support, provision of care services, and reviews of care and support plans.
In this interview, Clyde W. Yancy MD, MACC and Robert J. Mentz, MD, FACC examine definitions and treatment of ID in HF.
How the actual number of deaths in England compare with expected numbers for each week.
How the actual number of deaths in England compare with expected numbers for each week.
National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
by Saul Martin-Rodriguez, Rodrigo Fernandez-Gonzalo, David Moher Summary points Systematic reviews and meta-analyses underpin clinical guidelines and health policy, yet their validity may be compromised by limited access to underlying datasets and associated analytical code. Reliance on incomplete or inconsistently reported summary statistics forces researchers to use imputation and unverifiable assumptions, which can distort effect estimates and mislead clinical decision-making. The consequences extend beyond methodology: flawed evidence synthesis can influence treatment recommendations…
New FDA guidance on the use of Bayesian statistics signals a broader shift in accommodating more flexible clinical trial designs and the complexities of diseases such as certain cancers and rare disorders, which may lead to more efficient trials, lower development costs, and faster innovation. The post The FDA’s Bayesian Guidance Could Quietly Reshape Clinical Trial Design appeared first on MedCity News .
Supplementation with the vitamin K homologue menaquinone-7 (MK-7) significantly attenuated coronary artery calcification (CAC) compared with placebo in adults with symptomatic coronary artery disease (CAD), according to research published June 10 in JAMA Cardiology.
Administration of sodium bicarbonate made no significant difference in the sustained return of spontaneous circulation, compared with placebo, in patients who suffered an in-hospital cardiac arrest, according to research published June 11 in JAMA.
When compared with liberal oxygen therapy, conservative oxygen therapy did not improve rates of survival with favorable functional outcomes among unresponsive patients in the intensive care unit (ICU) receiving mechanical ventilation after cardiac arrest, according to results from the investigator-initiated, open-label LOGICAL trial published June 10 in NEJM.
Reframing transportation as infrastructure, not a support service, means holding it to the same standard as any other component of care delivery. That requires these three things. The post Healthcare Access Depends on Infrastructure: Why Rural Communities Can’t Afford Fragmentation appeared first on MedCity News .
The autonomous healthcare system is about to take shape, and health systems must prepare to evolve alongside it. The post Natural Selection Will Weed Out the Weak in the Race to Autonomous Healthcare appeared first on MedCity News .
Healthcare professionals should be aware of the potential for delayed onset of angioedema and the distinction between bradykinin- and histamine-mediated cases, as treatment strategies differ significantly and bradykinin-mediated angioedema does not respond to standard treatment.
The American Diabetes Association Applauds Governor Jeff Landry on the Passage of Senate Bill 433, Expanded Access to Obesity Medications for Medicaid Enrollees vcramer Tue, 06/16/2026 - 13:03 Advocacy News The American Diabetes Association Applauds Governor Jeff Landry on the Passage of Senate Bill 433, Expanded Access to Obesity Medications for Medicaid Enrollees Baton Rogue, LA June 16, 2026 The American Diabetes Association® (ADA) applauds Governor Jeff Landry and the Louisiana legislature for their bipartisan support of Senate Bill 433 (SB 433), landmark legislation expanding Medicaid…
Information on the Meningococcal B (MenB) time limited vaccination offer.
The American Diabetes Association Applauds Louisiana Lawmakers for Advancing Diabetes-Related Amputation Prevention through House Resolution 267 vcramer Tue, 06/16/2026 - 12:54 Advocacy News The American Diabetes Association Applauds Louisiana Lawmakers for Advancing Diabetes-Related Amputation Prevention through House Resolution 267 Baton Rogue, LA June 16, 2026 The American Diabetes Association® (ADA) applauds the Louisiana House of Representatives for passing House Resolution 267 (HR 267), a measure establishing a comprehensive study focused on the prevention and reduction…
Prescription to Nonprescription Switch List
Anyone can save a life during an opioid overdose with naloxone, a front-line defense in the opioid crisis. Naloxone is a life-saving drug that quickly reverses the powerful effects of opioids. FDA is working to give more people access to naloxone.
The U.S. Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone product, Rextovy, a 4 milligram (mg) naloxone hydrochloride nasal spray for the emergency treatment of opioid overdose.
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Efficacy supplement (new or revised indication). spray, metered, nasal. Sponsor: Amphastar Pharms Inc